Home/Filings/4/0000899243-23-016397
4//SEC Filing

Graves Kurt 4

Accession 0000899243-23-016397

CIK 0001609809other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 5:22 PM ET

Size

5.4 KB

Accession

0000899243-23-016397

Insider Transaction Report

Form 4
Period: 2023-06-22
Graves Kurt
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-22+35,00035,000 total
    Exercise: $5.46Exp: 2033-06-21Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1
  • filerCIK 0001406337

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 5:22 PM ET
Size
5.4 KB